BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest 2020;130:2777-88. [PMID: 32391806 DOI: 10.1172/JCI135530] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 31.0] [Reference Citation Analysis]
Number Citing Articles
1 Mussa BM, Srivastava A, Verberne AJM. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond. Viruses 2021;13:498. [PMID: 33802995 DOI: 10.3390/v13030498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Infantino R, Schiano C, Luongo L, Paino S, Mansueto G, Boccella S, Guida F, Ricciardi F, Iannotta M, Belardo C, Marabese I, Pieretti G, Serra N, Napoli C, Maione S. MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia. Neurobiol Dis 2022;164:105611. [PMID: 34995755 DOI: 10.1016/j.nbd.2022.105611] [Reference Citation Analysis]
3 Drag LL, Mlynash M, Nassar H, Osborn E, Kim DE, Angst MS, Aghaeepour N, Buckwalter M, Lansberg MG. A longitudinal study of the post-stroke immune response and cognitive functioning: the StrokeCog study protocol. BMC Neurol 2020;20:313. [PMID: 32847540 DOI: 10.1186/s12883-020-01897-9] [Reference Citation Analysis]
4 Garcia-Bonilla L, Sciortino R, Shahanoor Z, Racchumi G, Janakiraman M, Montaner J, Zhou P, Anrather J, Iadecola C. Role of microglial and endothelial CD36 in post-ischemic inflammasome activation and interleukin-1β-induced endothelial activation. Brain Behav Immun 2021;95:489-501. [PMID: 33872708 DOI: 10.1016/j.bbi.2021.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shi J, Yang Y, Yin N, Liu C, Zhao Y, Cheng H, Zhou T, Zhang Z, Zhang K. Engineering CXCL12 Biomimetic Decoy-Integrated Versatile Immunosuppressive Nanoparticle for Ischemic Stroke Therapy with Management of Overactivated Brain Immune Microenvironment. Small Methods 2022;6:e2101158. [PMID: 35041278 DOI: 10.1002/smtd.202101158] [Reference Citation Analysis]
6 Wang R, Wang X, Zhang Y, Zhao H, Cui J, Li J, Di L. Emerging prospects of extracellular vesicles for brain disease theranostics. Journal of Controlled Release 2022;341:844-68. [DOI: 10.1016/j.jconrel.2021.12.024] [Reference Citation Analysis]
7 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Reference Citation Analysis]
8 Pan R, Xie Y, Fang W, Liu Y, Zhang Y. USP20 mitigates ischemic stroke in mice by suppressing neuroinflammation and neuron death via regulating PTEN signal. Int Immunopharmacol 2021;103:107840. [PMID: 34953448 DOI: 10.1016/j.intimp.2021.107840] [Reference Citation Analysis]
9 Derk J, Jones HE, Como C, Pawlikowski B, Siegenthaler JA. Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease. Front Cell Neurosci 2021;15:703944. [PMID: 34276313 DOI: 10.3389/fncel.2021.703944] [Reference Citation Analysis]
10 Lourbopoulos A, Mourouzis I, Xinaris C, Zerva N, Filippakis K, Pavlopoulos A, Pantos C. Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal. Front Neurosci 2021;15:652403. [PMID: 34054413 DOI: 10.3389/fnins.2021.652403] [Reference Citation Analysis]
11 Wang YY, Lin SY, Chang CY, Wu CC, Chen WY, Liao SL, Chen YF, Wang WY, Chen CJ. Jak2 Inhibitor AG490 Improved Poststroke Central and Peripheral Inflammation and Metabolic Abnormalities in a Rat Model of Ischemic Stroke. Antioxidants (Basel) 2021;10:1958. [PMID: 34943061 DOI: 10.3390/antiox10121958] [Reference Citation Analysis]
12 Elkind MSV, Boehme AK, Smith CJ, Meisel A, Buckwalter MS. Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke. Stroke 2020;51:3156-68. [PMID: 32897811 DOI: 10.1161/STROKEAHA.120.030429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
13 Zeng S, Zhao Z, Zheng S, Wu M, Song X, Li Y, Zheng Y, Liu B, Chen L, Gao C, Liu H. The E3 ubiquitin ligase TRIM31 is involved in cerebral ischemic injury by promoting degradation of TIGAR. Redox Biol 2021;45:102058. [PMID: 34218200 DOI: 10.1016/j.redox.2021.102058] [Reference Citation Analysis]
14 Li W, Hou M, Ding Z, Liu X, Shao Y, Li X. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis. Front Neurol 2021;12:686983. [PMID: 34630275 DOI: 10.3389/fneur.2021.686983] [Reference Citation Analysis]
15 Schmidt C, Schneble-Löhnert N, Lajqi T, Wetzker R, Müller JP, Bauer R. PI3Kγ Mediates Microglial Proliferation and Cell Viability via ROS. Cells 2021;10:2534. [PMID: 34685514 DOI: 10.3390/cells10102534] [Reference Citation Analysis]
16 Strinitz M, Pham M, März AG, Feick J, Weidner F, Vogt ML, Essig F, Neugebauer H, Stoll G, Schuhmann MK, Kollikowski AM. Immune Cells Invade the Collateral Circulation during Human Stroke: Prospective Replication and Extension. Int J Mol Sci 2021;22:9161. [PMID: 34502070 DOI: 10.3390/ijms22179161] [Reference Citation Analysis]
17 Ghelani DP, Kim HA, Zhang SR, Drummond GR, Sobey CG, De Silva TM. Ischemic stroke and infection: A brief update on mechanisms and potential therapies. Biochem Pharmacol 2021;193:114768. [PMID: 34543657 DOI: 10.1016/j.bcp.2021.114768] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Neelakandan AR, Bae O, Majid A, Burak CA, Rajanikant GK. Neuroprotective Potential of Carnosine in Cerebrovascular Diseases. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-021-10342-5] [Reference Citation Analysis]
19 Muhammad S, Chaudhry SR, Kahlert UD, Niemelä M, Hänggi D. Brain Immune Interactions-Novel Emerging Options to Treat Acute Ischemic Brain Injury. Cells 2021;10:2429. [PMID: 34572077 DOI: 10.3390/cells10092429] [Reference Citation Analysis]
20 Di Cataldo V, Debatisse J, Piraquive J, Géloën A, Grandin C, Verset M, Taborik F, Labaronne E, Loizon E, Millon A, Mury P, Pialoux V, Serusclat A, Lamberton F, Ibarrola D, Lavenne F, Le Bars D, Troalen T, Confais J, Crola Da Silva C, Mechtouff L, Contamin H, Fayad ZA, Canet-Soulas E. Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model. Brain Commun 2021;3:fcab064. [PMID: 33937770 DOI: 10.1093/braincomms/fcab064] [Reference Citation Analysis]
21 Buckley MW, Mcgavern DB. Immune dynamics in the CNS and its barriers during homeostasis and disease*. Immunological Reviews. [DOI: 10.1111/imr.13066] [Reference Citation Analysis]
22 Jin W, Wu Y, Chen N, Wang Q, Wang Y, Li Y, Li S, Han X, Yang E, Tong F, Wu J, Yuan X, Kang C. Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke. Theranostics 2021;11:8197-217. [PMID: 34373737 DOI: 10.7150/thno.58947] [Reference Citation Analysis]
23 Finger CE, Moreno-Gonzalez I, Gutierrez A, Moruno-Manchon JF, McCullough LD. Age-related immune alterations and cerebrovascular inflammation. Mol Psychiatry 2021. [PMID: 34711943 DOI: 10.1038/s41380-021-01361-1] [Reference Citation Analysis]
24 McCullough LD, Moro MA. Translational Interdisciplinary Science-Immune Cell Niches: Possible Targets for Stroke Therapy? Stroke 2021;52:3692-5. [PMID: 34619983 DOI: 10.1161/STROKEAHA.121.033969] [Reference Citation Analysis]
25 Ahmed W, White IR, Wilkinson M, Johnson CF, Rattray N, Kishore AK, Goodacre R, Smith CJ, Fowler SJ. Breath and plasma metabolomics to assess inflammation in acute stroke. Sci Rep 2021;11:21949. [PMID: 34753981 DOI: 10.1038/s41598-021-01268-5] [Reference Citation Analysis]
26 Yew WP, Djukic ND, Jayaseelan JSP, Woodman RJ, Muyderman H, Sims NR. Differential effects of the cell cycle inhibitor, olomoucine, on functional recovery and on responses of peri-infarct microglia and astrocytes following photothrombotic stroke in rats. J Neuroinflammation 2021;18:168. [PMID: 34332596 DOI: 10.1186/s12974-021-02208-w] [Reference Citation Analysis]
27 Greco R, Demartini C, Zanaboni AM, Tumelero E, Persico A, Candeloro E, Morotti A, Amantea D, Tassorelli C. CD163 as a Potential Biomarker of Monocyte Activation in Ischemic Stroke Patients. Int J Mol Sci 2021;22:6712. [PMID: 34201498 DOI: 10.3390/ijms22136712] [Reference Citation Analysis]
28 Shen Y, Yang R, Zhou R, Lu W, Li L, Niu Z, Chen M, Wang J, Wang Y, Fang L, Du G. Xiaoxuming Decoction Regulates Vascular Function by Modulating G Protein-Coupled Receptors: A Molecular Docking Study. Biomed Res Int 2021;2021:5575443. [PMID: 34195269 DOI: 10.1155/2021/5575443] [Reference Citation Analysis]
29 Alam JJ, Krakovsky M, Germann U, Levy A. Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level. PLoS One 2020;15:e0233073. [PMID: 33275615 DOI: 10.1371/journal.pone.0233073] [Reference Citation Analysis]
30 Forte M, Marchitti S, Cotugno M, Di Nonno F, Stanzione R, Bianchi F, Schirone L, Schiavon S, Vecchio D, Sarto G, Scioli M, Raffa S, Tocci G, Relucenti M, Torrisi MR, Valenti V, Versaci F, Vecchione C, Volpe M, Frati G, Rubattu S, Sciarretta S. Trehalose, a natural disaccharide, reduces stroke occurrence in the stroke-prone spontaneously hypertensive rat. Pharmacol Res 2021;173:105875. [PMID: 34500062 DOI: 10.1016/j.phrs.2021.105875] [Reference Citation Analysis]
31 Candelario-Jalil E, Paul S. Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective. Exp Neurol 2021;335:113494. [PMID: 33035516 DOI: 10.1016/j.expneurol.2020.113494] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
32 Niu X, Cheng Y, Zhang M, Du L, Wu X, Lu C, Li X, Liu S, Zhao A, Zhang S, Wu Z, Ding B, Shi W, Wang C, Yang Y, Tian Y. Neuroprotective Effects of Omentin-1 Against Cerebral Hypoxia/Reoxygenation Injury via Activating GAS6/Axl Signaling Pathway in Neuroblastoma Cells. Front Cell Dev Biol 2022;9:784035. [DOI: 10.3389/fcell.2021.784035] [Reference Citation Analysis]
33 Nikolic D, Jankovic M, Petrovic B, Novakovic I. Genetic Aspects of Inflammation and Immune Response in Stroke. Int J Mol Sci 2020;21:E7409. [PMID: 33049931 DOI: 10.3390/ijms21197409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell 2020;183:16-27.e1. [PMID: 32882182 DOI: 10.1016/j.cell.2020.08.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 141] [Article Influence: 67.0] [Reference Citation Analysis]
35 Li C, Sun G, Chen B, Xu L, Ye Y, He J, Bao Z, Zhao P, Miao Z, Zhao L, Hu J, You Y, Liu N, Chao H, Ji J. Nuclear receptor coactivator 4-mediated ferritinophagy contributes to cerebral ischemia-induced ferroptosis in ischemic stroke. Pharmacol Res 2021;174:105933. [PMID: 34634471 DOI: 10.1016/j.phrs.2021.105933] [Reference Citation Analysis]